PAVmed stockholders approve reverse stock split and authorized share reduction

PAVmed Inc.

Approximately 70.8% of shares present or represented at March 31 special meeting.
Reverse split ratio range 1:5 to 1:15, board to decide timing and exact ratio by March 31, 2024.
Authorized shares reduced from 250M to 50M upon effectuation of reverse split.
Votes: 53,080,020 for, 15,037,559 against, 1,009,870 abstain, no broker non-votes.
Company reserved right to abandon the reverse split and authorized capital reduction.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

PAVmed Inc. shareholders approved A proposal to approve an amendment to the certificate of incorporation to effect a reverse stock split and an associated reduction in authorized shares at the 2023-03-31 meeting.

Proposal: reverse split
Outcome: passed
Meeting: 2023-03-31

Exact text from the filing

Stockholders representing approximately 70.8% of the shares outstanding and entitled to vote were present in person or by proxy. At the Special Meeting, the stockholders approved the sole proposal presented.

View on SEC.gov

Browse all shareholder votes →

PAVmed Inc. filing history →

Source: SEC EDGAR

accession 0001493152-23-010378

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.